Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
44.51
+1.01 (2.32%)
At close: Jun 26, 2026, 4:00 PM EDT
44.69
+0.18 (0.40%)
After-hours: Jun 26, 2026, 7:32 PM EDT
Astrana Health Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Astrana Health stock have an average target of 44.5, with a low estimate of 36 and a high estimate of 50. The average target predicts a decrease of -0.02% from the current stock price of 44.51.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Reiterates $50 | Buy | Reiterates | $50 | +12.33% | Jun 2, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 1, 2026 |
| Barclays | Barclays | Buy Upgrades $37 → $50 | Buy | Upgrades | $37 → $50 | +12.33% | May 26, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 13, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $35 → $45 | Buy | Reiterates | $35 → $45 | +1.10% | May 12, 2026 |
Financial Forecast
Revenue This Year
4.00B
from 3.18B
Increased by 25.82%
Revenue Next Year
4.38B
from 4.00B
Increased by 9.35%
EPS This Year
2.92
from 2.12
Increased by 37.57%
EPS Next Year
3.41
from 2.92
Increased by 16.78%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.1B | 4.6B | |
| Avg | 4.0B | 4.4B | |
| Low | 3.9B | 4.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.5% | 14.5% | |
| Avg | 25.8% | 9.4% | |
| Low | 24.1% | 5.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.99 | 3.48 | |
| Avg | 2.92 | 3.41 | |
| Low | 2.85 | 3.34 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.9% | 19.2% | |
| Avg | 37.6% | 16.8% | |
| Low | 34.3% | 14.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.